Weight-loss jab could be made for $3 a month, study finds
Cheap semaglutide, the drug in Ozempic and Wegovy, could help millions with diabetes and obesity in 160 countries Weight-loss jabs such as Wegovy and Ozempic could be made for just $3 a month, according to new analysis, potentially making the treatment available to millions in poorer countries as patents expire. More than a billion people live with obesity worldwide, with rates rising fast in lower-income nations as they shift to Westernised diets and more sedentary lifestyles. The World Health Organisation designated semaglutide – sold to treat obesity under the brand name Wegovy and diabetes under the brand name Ozempic – as an essential medicine in September…
